CN118001330A - 一种用于女性健康的妇科洗液配方及制作方法 - Google Patents
一种用于女性健康的妇科洗液配方及制作方法 Download PDFInfo
- Publication number
- CN118001330A CN118001330A CN202410062401.3A CN202410062401A CN118001330A CN 118001330 A CN118001330 A CN 118001330A CN 202410062401 A CN202410062401 A CN 202410062401A CN 118001330 A CN118001330 A CN 118001330A
- Authority
- CN
- China
- Prior art keywords
- mixed solution
- parts
- alcohol
- female health
- gynecological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 42
- 229960002152 chlorhexidine acetate Drugs 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 67
- 239000011259 mixed solution Substances 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 15
- 241000411851 herbal medicine Species 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 238000001556 precipitation Methods 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 12
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 11
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 11
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 11
- 229940116229 borneol Drugs 0.000 claims description 11
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 11
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 11
- 229940041616 menthol Drugs 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 244000178870 Lavandula angustifolia Species 0.000 claims description 8
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 8
- 239000001102 lavandula vera Substances 0.000 claims description 8
- 235000018219 lavender Nutrition 0.000 claims description 8
- 238000009210 therapy by ultrasound Methods 0.000 claims description 8
- 240000003690 Callicarpa japonica Species 0.000 claims description 7
- 235000017595 Callicarpa japonica Nutrition 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 241000903946 Clematidis Species 0.000 claims description 6
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 239000010619 basil oil Substances 0.000 claims description 5
- 229940018006 basil oil Drugs 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 239000006184 cosolvent Substances 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000003809 water extraction Methods 0.000 claims description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 3
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 3
- 240000001851 Artemisia dracunculus Species 0.000 claims description 3
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 3
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 3
- 244000020518 Carthamus tinctorius Species 0.000 claims description 3
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 3
- 239000005770 Eugenol Substances 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 235000013717 Houttuynia Nutrition 0.000 claims description 3
- 240000000691 Houttuynia cordata Species 0.000 claims description 3
- 241000972672 Phellodendron Species 0.000 claims description 3
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 239000001138 artemisia absinthium Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229960002217 eugenol Drugs 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 3
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- 240000007926 Ocimum gratissimum Species 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 2
- 241000404844 Callicarpa nudiflora Species 0.000 claims 1
- 235000010676 Ocimum basilicum Nutrition 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 206010061218 Inflammation Diseases 0.000 abstract description 13
- 230000004054 inflammatory process Effects 0.000 abstract description 13
- 241000894006 Bacteria Species 0.000 abstract description 10
- 208000015181 infectious disease Diseases 0.000 abstract description 6
- 241000222122 Candida albicans Species 0.000 abstract description 4
- 241000233866 Fungi Species 0.000 abstract description 4
- 244000052616 bacterial pathogen Species 0.000 abstract description 4
- 229940095731 candida albicans Drugs 0.000 abstract description 4
- 229940126678 chinese medicines Drugs 0.000 abstract description 4
- 229940126673 western medicines Drugs 0.000 abstract description 3
- -1 compound chlorhexidine acetate Chemical class 0.000 abstract description 2
- 206010061977 Genital infection female Diseases 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 208000024386 fungal infectious disease Diseases 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 206010046914 Vaginal infection Diseases 0.000 description 8
- 201000008100 Vaginitis Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000001215 vagina Anatomy 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241001529734 Ocimum Species 0.000 description 2
- 235000011205 Ocimum Nutrition 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 235000004066 Ocimum gratissimum Nutrition 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及妇科保健治疗技术领域,具体涉及一种用于女性健康的妇科洗液配方及制作方法,采取中西结合的理念,结合中药和西药成分中的有效成分,可以抑制细菌、真菌和白色念珠菌等致病菌的生长和繁殖,减少感染引起的炎症,具有综合的治疗效果,同时加特定的成分来调节私密部位的pH值,使其保持在健康范围内,对预防细菌、真菌感染等能起到一定的保护左右;考虑到女性私密部位的皮肤可能比较敏感,选择温和的成分,减少对皮肤的刺激;复合醋酸氯己定妇科洗液具有广谱抑菌、持久抑菌、快速杀菌等多种效果,它可以用于日常清洁护理,也可用于辅助治疗妇科感染。
Description
技术领域
本发明涉及妇科保健治疗技术领域,尤其涉及一种用于女性健康的妇科洗液配方及制作方法。
背景技术
近年来,女性的健康问题越来越受到关注。其中,妇科疾病是女性常见的一种疾病,严重影响着女性的生活和工作。妇科疾病的种类有很多,常见的疾病为阴道炎、尿道炎、盆腔炎、宫颈炎。其中,名列首位的女性疾病就是阴道炎,占妇科患病人数的4成左右。具体的症状有:外阴异常瘙痒,时有灼痛感,阴道分泌物增多,有些许异味等。这些疾病如果没有及时得到治疗,会给女性的生活以及健康带来重大危害。
临床西医治疗阴道炎主要以口服抗菌药和阴道栓剂、洗液疗法为主,如氟康唑、诺康唑、碳酸氢钠洗液、达克宁栓等药物,口服类药物西医以抗菌药物为主,易产生耐药性,且用量不当可能会引起菌群失调而致经久不愈的阴道炎,或出现胃肠道不适、皮疹等不良反应,中医认为,阴道炎是由于寒湿内生、湿毒蕴结等因素引起的,因此中医治疗重点在于温化寒湿、祛湿毒、调整人体平衡,常使用中药来调整患者的体内平衡,常用的中药有黄柏、苦参、金银花、裸花紫珠等,具有抗菌、消炎、抗病毒等作用,但中医治疗阴道炎常常需要长期治疗,可能需要几个月甚至更长时间才能获得满意的治疗效果,不适用于急性症状,外用疗法中,涉及到的妇科洗液产品主要以中成药、抗生素和化学合成药物为主要成分,此三类产品的弊端在于:中药制剂产品普遍存在药效较慢治疗期相对较长的问题,pH值一般呈中性甚至碱性;抗生素产品容易产生耐药性,且易破坏阴道菌群平衡,在使用后炎症复发率高;而化学合成药毒副作用相对较大,使用后炎症复发率高,且复发后难治愈。
发明内容
本发明的目的在于提供一种用于女性健康的妇科洗液配方及制作方法,结合中药和西药成分中的有效成分,可以抑制细菌、真菌和白色念珠菌等致病菌的生长和繁殖,减少感染引起的炎症,适用于治疗各种细菌性阴道炎、念珠菌性阴道炎等,具有综合的治疗效果。
为实现上述目的,本发明提供了一种用于女性健康的妇科洗液制作方法,包括以下步骤:
将下列中草药:裸花紫珠、蛇床子、红花、黄柏、苦参、鱼腥草、威灵仙和艾草按照指定数量进行破壁粉碎,之后对混合液进行工艺处理和提取;
将上述提取后的药液进行过滤和浓缩;
将上述浓缩液加入指定浓度的酒精进行醇沉,然后采用离心和回收乙醇的操作制成混合液A;
将指定数量的冰片和薄荷脑研碎,然后加入助溶剂使其搅拌溶解,之后加入指定数量的甘油、醋酸氯己定、丁香罗勒油和薰衣草精油,最终混匀得到混合液B备用;
将混合液A与混合液B按照设定比例加入指定数量的纯化水进行搅拌混合,之后加入乳酸将混合液PH值调至3.5-4.5即可。
其中,对混合液进行工艺处理和提取的具体方法为:
加入8-10倍质量的水与破壁粉碎的中草药进行均匀搅拌和混合;
采用添加醋酸混合液以及指定数量的复合酶保证混合液PH值在3.8-5之间,同时保持混合液温度在50℃-55℃之间;
在水解指定时间后进行间隔翻搅然后采用超声处理,之后将处理完成的药液进行转移升温和后续提取。
其中,药液进行过滤和浓缩的具体方法为:
将提取好的中药药液放置在阴凉干燥处静置;
当药液静置到室温后进行缓慢过滤;
对滤液进行浓缩,直到浓缩至原来中草药液质量的五分之一。
其中,浓缩液加入指定浓度的酒精进行醇沉具体方法为:
朝浓缩液加入95%的酒精,加入酒精时边加酒精边搅拌;
通过加入酒精使得混合液酒精度达到65%-70%,然后将混合液放置到室温;
最后将混合液置于10℃的环境中36小时。
其中,采用离心和回收乙醇的操作制成混合液A具体方法为:
将醇沉液进行离心,转速3500r/min,离心时间为15分钟;
取上层清液备用,然后将上述离心液转移到减压蒸馏设备中,在-0.1MPa压力,80℃下回收乙醇;
到混合液闻不到乙醇味便可将回收乙醇后的混合液A放凉至室温备用。
其中,药液进行转移升温和后续提取具体方法为:
将超声处理结束后的中草药液转移到提取罐;
将水温升高至100℃,然后进行水提取2小时左右。
本发明的一种用于女性健康的妇科洗液配方及制作方法,采取中西结合的理念,结合中药和西药成分中的有效成分,可以抑制细菌、真菌和白色念珠菌等致病菌的生长和繁殖,减少感染引起的炎症,适用于治疗各种细菌性阴道炎、念珠菌性阴道炎等,具有综合的治疗效果,本配方还结合中药的天然活性成分和西药的科学配方,发挥双重优势,提供更全面的治疗作用,同时产品pH值呈弱酸性,薰衣草精油和丁香罗勒油被认为具有调节阴道酸碱平衡的作用,可以维持阴道内适宜的酸碱度,促进正常的阴道菌群生态平衡,减少炎症和感染的发生,在使用时避免破坏人体内正常酸碱平衡,使阴道保持在酸性环境(pH值低于4.5),这有助于抑制病原微生物的生长,而且本配方含有苦参、裸花紫珠等中药材,具有抗菌、抗炎、抗氧化等作用,这些成分可以帮助清除阴道内的病原微生物,减少感染的风险,并减轻炎症引起的不适感,妇科洗液中还添加了天然冰片及薄荷脑,冰片和薄荷脑都具有清凉的特性,含有挥发油类成分,可以提供清凉的效果的同时,还起到一定的抗菌和抗炎作用,缓解阴部不适、瘙痒等症状。
附图说明
为了更清楚地说明本申请实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍。
图1是用于女性健康的妇科洗液制作方法的步骤图。
具体实施方式
下面详细描述本发明的实施例,所述实施例的示例在附图中示出,下面通过参考附图描述的实施例是示例性的,旨在用于解释本发明,而不能理解为对本发明的限制。
本申请的实施例为:
请参阅图1,其中图1是用于女性健康的妇科洗液制作方法的步骤图。
本发明一种用于女性健康的妇科洗液配方的主要成分包括醋酸氯己定4-8份、冰片0.2-0.5份、薄荷脑0.2-0.5份、丁香罗勒油0.1-0.3份、薰衣草精油0.1-0.3份、裸花紫珠1-3份、蛇床子0.2-1份、红花1-3份、黄柏1-3份、苦参1-3份、鱼腥草1-3份、威灵仙0.5-2份、艾草0.5-2份、丙二醇40-60份、乙醇15-25份、甘油45-60份、乳酸1-3份、纯化水700-900份组成;经过粉碎、浸泡、提取、过滤及浓缩、醇沉、离心、回收乙醇、溶解、配制等工艺制作而成。
本发明提供一种用于女性健康的妇科洗液制作方法,包括以下步骤:
S1:将下列中草药:裸花紫珠、蛇床子、红花、黄柏、苦参、鱼腥草、威灵仙和艾草按照指定数量进行破壁粉碎,之后对混合液进行工艺处理和提取;
同时,对混合液进行工艺处理和提取的具体方法为:
S11:加入8-10倍质量的水与破壁粉碎的中草药进行均匀搅拌和混合;
S12:采用添加醋酸混合液以及指定数量的复合酶保证混合液PH值在3.8-5之间,同时保持混合液温度在50℃-55℃之间;
S13:在水解指定时间后进行间隔翻搅然后采用超声处理,之后将处理完成的药液进行转移升温和后续提取;
其次,药液进行转移升温和后续提取具体方法为:
S131:将超声处理结束后的中草药液转移到提取罐;
S132:将水温升高至100℃,然后进行水提取2小时左右。
具体的,将下述中草药:裸花紫珠1-3份、蛇床子0.2-1份、红花1-3份、黄柏1-3份、苦参1-3份、鱼腥草1-3份、威灵仙0.5-2份、艾草0.5-2份,进行破壁粉碎,再加入8-10倍质量的水中,搅拌均匀,用醋酸调节混合液的PH使其为3.8-5之间,加入复合酶(含半纤维素酶、果胶酶、β-葡聚糖酶)质量为中草药质量的5%,保持混合液的温度为50℃-55℃,水解时间8-12小时,中间每隔半个小时翻搅一次,水解完成后将水解液倒入超声机对水解液进行超声处理,超声功率为240W,超声波频率为40Hz,超声时间为30分钟,超声结束后将中草药液转移到提取罐,升高水温至100℃,进行水提取2小时左右。
S2:将上述提取后的药液进行过滤和浓缩;
同时,药液进行过滤和浓缩的具体方法为:
S21:将提取好的中药药液放置在阴凉干燥处静置;
S22:当药液静置到室温后进行缓慢过滤;
S23:对滤液进行浓缩,直到浓缩至原来中草药液质量的五分之一;
在本实施方式中,所述加工箱101放置在地面上,所述进料漏斗102与所述加工箱101顶部具有的进料口对应固定安装,使得可以通过所述进料漏斗102将加工物料倒入所述加工箱101内。
具体的,将上诉提取好的中草药液置于阴凉干燥处静置至室温后,缓慢过滤,滤液进行浓缩,浓缩至原来中草药液质量的五分之一。
S3:将上述浓缩液加入指定浓度的酒精进行醇沉,然后采用离心和回收乙醇的操作制成混合液A;
同时,浓缩液加入指定浓度的酒精进行醇沉具体方法为:
S301:朝浓缩液加入95%的酒精,加入酒精时边加酒精边搅拌;
S302:通过加入酒精使得混合液酒精度达到65%-70%,然后将混合液放置到室温;
S303:最后将混合液置于10℃的环境中36小时;
其次,采用离心和回收乙醇的操作制成混合液A具体方法为:
S311:将醇沉液进行离心,转速3500r/min,离心时间为15分钟;
S312:取上层清液备用,然后将上述离心液转移到减压蒸馏设备中,在-0.1MPa压力,80℃下回收乙醇;
S313:到混合液闻不到乙醇味便可将回收乙醇后的混合液A放凉至室温备用;
具体的,往上诉浓缩液中加入95%的酒精,对中草药液进行醇沉,边加酒精边搅拌,转速50r/min,使混合液的酒精度达到65%-70%,将其放置到室温,再将混合液置于10℃的环境中36小时,将上述醇沉液进行离心,转速3500r/min,离心时间为15分钟,取上层清液备用,将上诉离心液转移到减压蒸馏设备中,在-0.1MPa压力,80℃下回收乙醇,直至混合液闻不到乙醇味,将回收乙醇后的混合液A放凉至室温备用。
S4:将指定数量的冰片和薄荷脑研碎,然后加入助溶剂使其搅拌溶解,之后加入指定数量的甘油、醋酸氯己定、丁香罗勒油和薰衣草精油,最终混匀得到混合液B备用;
具体的,将冰片0.2-0.5份、薄荷脑0.2-0.5份进行研碎,然后加入助溶剂(乙醇、丙二醇)40-100份,搅拌使其溶解,加入甘油45-60份、醋酸氯己定4-8份、丁香罗勒油0.1-0.3份、薰衣草精油0.1-0.3份,混匀得到混合液B备用。
S5:将混合液A与混合液B按照设定比例加入指定数量的纯化水进行搅拌混合,之后加入乳酸将混合液PH值调至3.5-4.5即可;
具体的,取5-15份上述混合液A加入混合液B中,在加入纯化水700-900份,搅拌30分钟,充分混合均匀后,加入乳酸10-20份调节PH值3.5-4.5即可。
本发明的一种用于女性健康的妇科洗液配方及制作方法,采取中西结合的理念,结合中药和西药成分中的有效成分,可以抑制细菌、真菌和白色念珠菌等致病菌的生长和繁殖,减少感染引起的炎症,适用于治疗各种细菌性阴道炎、念珠菌性阴道炎等,具有综合的治疗效果,本配方还结合中药的天然活性成分和西药的科学配方,发挥双重优势,提供更全面的治疗作用,同时产品pH值呈弱酸性,薰衣草精油和丁香罗勒油被认为具有调节阴道酸碱平衡的作用,可以维持阴道内适宜的酸碱度,促进正常的阴道菌群生态平衡,减少炎症和感染的发生,在使用时避免破坏人体内正常酸碱平衡,使阴道保持在酸性环境(pH值低于4.5),这有助于抑制病原微生物的生长,而且本配方含有苦参、裸花紫珠等中药材,具有抗菌、抗炎、抗氧化等作用,这些成分可以帮助清除阴道内的病原微生物,减少感染的风险,并减轻炎症引起的不适感,妇科洗液中还添加了天然冰片及薄荷脑,冰片和薄荷脑都具有清凉的特性,含有挥发油类成分,可以提供清凉的效果的同时,还起到一定的抗菌和抗炎作用,缓解阴部不适、瘙痒等症状。
以上所揭露的仅为本申请一种或多种较佳实施例而已,不能以此来限定本申请之权利范围,本领域普通技术人员可以理解实现上述实施例的全部或部分流程,并依本申请权利要求所作的等同变化,仍属于本申请所涵盖的范围。
Claims (7)
1.一种用于女性健康的妇科洗液制作方法,其特征在于,包括以下步骤:
将下列中草药:裸花紫珠、蛇床子、红花、黄柏、苦参、鱼腥草、威灵仙和艾草按照指定数量进行破壁粉碎,之后对混合液进行工艺处理和提取;
将上述提取后的药液进行过滤和浓缩;
将上述浓缩液加入指定浓度的酒精进行醇沉,然后采用离心和回收乙醇的操作制成混合液A;
将指定数量的冰片和薄荷脑研碎,然后加入助溶剂使其搅拌溶解,之后加入指定数量的甘油、醋酸氯己定、丁香罗勒油和薰衣草精油,最终混匀得到混合液B备用;
将混合液A与混合液B按照设定比例加入指定数量的纯化水进行搅拌混合,之后加入乳酸将混合液PH值调至3.5-4.5即可。
2.如权利要求1所述的用于女性健康的妇科洗液制作方法,其特征在于,
对混合液进行工艺处理和提取的具体方法为:
加入8-10倍质量的水与破壁粉碎的中草药进行均匀搅拌和混合;
采用添加醋酸混合液以及指定数量的复合酶保证混合液PH值在3.8-5之间,同时保持混合液温度在50℃-55℃之间;
在水解指定时间后进行间隔翻搅然后采用超声处理,之后将处理完成的药液进行转移升温和后续提取。
3.如权利要求2所述的用于女性健康的妇科洗液制作方法,其特征在于,
药液进行过滤和浓缩的具体方法为:
将提取好的中药药液放置在阴凉干燥处静置;
当药液静置到室温后进行缓慢过滤;
对滤液进行浓缩,直到浓缩至原来中草药液质量的五分之一。
4.如权利要求3所述的用于女性健康的妇科洗液制作方法,其特征在于,
浓缩液加入指定浓度的酒精进行醇沉具体方法为:
朝浓缩液加入95%的酒精,加入酒精时边加酒精边搅拌;
通过加入酒精使得混合液酒精度达到65%-70%,然后将混合液放置到室温;
最后将混合液置于10℃的环境中36小时。
5.如权利要求4所述的用于女性健康的妇科洗液制作方法,其特征在于,
采用离心和回收乙醇的操作制成混合液A具体方法为:
将醇沉液进行离心,转速3500r/min,离心时间为15分钟;
取上层清液备用,然后将上述离心液转移到减压蒸馏设备中,在-0.1MPa压力,80℃下回收乙醇;
到混合液闻不到乙醇味便可将回收乙醇后的混合液A放凉至室温备用。
6.如权利要求2所述的用于女性健康的妇科洗液制作方法,其特征在于,
药液进行转移升温和后续提取具体方法为:
将超声处理结束后的中草药液转移到提取罐;
将水温升高至100℃,然后进行水提取2小时左右。
7.一种用于女性健康的妇科洗液配方,如权利要求1至权利要求6任一项所述的用于女性健康的妇科洗液制作方法应用于所述一种用于女性健康的妇科洗液配方,其特征在于,
所述用于女性健康的妇科洗液配方包括醋酸氯己定4-8份、冰片0.2-0.5份、薄荷脑0.2-0.5份、丁香罗勒油0.1-0.3份、薰衣草精油0.1-0.3份、裸花紫珠1-3份、蛇床子0.2-1份、红花1-3份、黄柏1-3份、苦参1-3份、鱼腥草1-3份、威灵仙0.5-2份、艾草0.5-2份、丙二醇40-60份、乙醇15-25份、甘油45-60份、乳酸1-3份、纯化水700-900份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410062401.3A CN118001330A (zh) | 2024-01-16 | 2024-01-16 | 一种用于女性健康的妇科洗液配方及制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410062401.3A CN118001330A (zh) | 2024-01-16 | 2024-01-16 | 一种用于女性健康的妇科洗液配方及制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118001330A true CN118001330A (zh) | 2024-05-10 |
Family
ID=90947159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410062401.3A Pending CN118001330A (zh) | 2024-01-16 | 2024-01-16 | 一种用于女性健康的妇科洗液配方及制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118001330A (zh) |
-
2024
- 2024-01-16 CN CN202410062401.3A patent/CN118001330A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102470117B (zh) | 一种以苯甲酸和有机酸防腐剂相联合作为有效成分的组合物及其用途 | |
CN102949647B (zh) | 一种杀菌止痒的药物组合物及其制法 | |
CN109078165A (zh) | 一种用于女性私处护理的组合物及其制备方法与应用 | |
CN105362351A (zh) | 用于治疗皮肤瘙痒病症的药物组合物及其应用 | |
CN106420493A (zh) | 一种具有消炎抑菌功效的透明质酸牙膏及其制作方法 | |
CN108853287B (zh) | 一种抗人乳头瘤病毒及抗妇科炎症的药物组合物、凝胶制剂及应用 | |
CN112316017A (zh) | 一种妇科抑菌凝胶及其制备方法 | |
CN105168385B (zh) | 一种抗菌止痒的药物组合物及其制备方法 | |
CN114712440A (zh) | 一种舒缓老年皮肤瘙痒症的傣药组合物及其制剂与应用 | |
CN104547303A (zh) | 一种治疗妇科炎症的外用凝胶剂及其制备方法 | |
CN104888058B (zh) | 一种抑菌、消炎外用制剂及其制备方法 | |
CN107496792B (zh) | 一种消炎抗菌治疗灰指甲的凝胶剂及其制备方法 | |
CN102397444A (zh) | 一种纳米级妇科洗液及其制备方法 | |
CN111658564A (zh) | 一种妇科外阴泡沫洗液及其制备方法 | |
CN1298731A (zh) | 一种妇科千金胶囊的制造方法 | |
CN118001330A (zh) | 一种用于女性健康的妇科洗液配方及制作方法 | |
CN110623993A (zh) | 治疗妇科炎症的中药组合物的复合营养片及其制备方法 | |
CN108938703A (zh) | 快速抗菌的妇科凝胶 | |
CN108785384A (zh) | 一种用于治疗痤疮的含锌中药组合物及其制剂 | |
CN102973680B (zh) | 一种用于治疗浅部真菌感染的外用搽剂及其制备方法 | |
CN105816551A (zh) | 一种用于妇科病及女性外生殖器官养护的药膜及制备方法 | |
CN105456849A (zh) | 一种抗菌、抑菌、杀菌的外伤护理组合物及其制备方法 | |
CN102462768A (zh) | 一种女性外用护理液 | |
CN103720930B (zh) | 一种治疗奶牛乳腺炎的中药组合物 | |
CN108114029A (zh) | 一种中药活性物组合物、其制备方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |